Projects funded by the NCN
Targeting Energy Metabolism for Precision Cancer Therapy: Novel Inhibitors of LDH-A and PDK1 as Potential Strategies to Starve Non-Small Cell Lung Cancer and Malignant Pleural Mesothelioma Cells
2023/49/N/NZ7/01893
Keywords:
targeted therapy energy metabolism lactate dehydrogenase A pyruvate dehydrogenase kinase 1 glucose transporter 1 non-small cell lung cancer malignant pleural mesothelioma
Descriptors:
- NZ1_2: Biochemistry
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ4_11: Metabolism
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Gdański Uniwersytet Medyczny, Wydział Lekarski
woj. pomorskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 22 - announced on 2023-03-16
Amount awarded: 137 478 PLN
Project start date (Y-m-d): 2024-01-09
Project end date (Y-m-d): 2026-01-08
Project duration:: 24 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.